BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1701072)

  • 1. Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization.
    Dietrich W; Spannagl M; Jochum M; Wendt P; Schramm W; Barankay A; Sebening F; Richter JA
    Anesthesiology; 1990 Dec; 73(6):1119-26. PubMed ID: 1701072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
    Kawasuji M; Ueyama K; Sakakibara N; Tedoriya T; Matsunaga Y; Misaki T; Watanabe Y
    Ann Thorac Surg; 1993 May; 55(5):1205-9. PubMed ID: 7684219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clotting and fibrinolytic disturbance during lung transplantation: effect of low-dose aprotinin. Groningen Lung Transplant Group.
    Gu YJ; de Haan J; Brenken UP; de Boer WJ; Prop J; Van Oeveren W
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):599-606. PubMed ID: 8800145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
    Dietrich W; Mössinger H; Spannagl M; Jochum M; Wendt P; Barankay A; Meisner H; Richter JA
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation.
    Havel M; Teufelsbauer H; Knöbl P; Dalmatiner R; Jaksch P; Zwölfer W; Müller M; Vukovich T
    J Thorac Cardiovasc Surg; 1991 Jun; 101(6):968-72. PubMed ID: 1710009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response.
    Koster A; Huebler S; Merkle F; Hentschel T; Gründel M; Krabatsch T; Tambeur L; Praus M; Habazettl H; Kuebler WM; Kuppe H
    Anesth Analg; 2004 Feb; 98(2):285-290. PubMed ID: 14742356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
    Lu H; Du Buit C; Soria J; Touchot B; Chollet B; Commin PL; Conseiller C; Echter E; Soria C
    Thromb Haemost; 1994 Sep; 72(3):438-43. PubMed ID: 7531877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation.
    Verma YS; Chauhan S; Bisoi AK; Gharde P; Kiran U; Das SN
    Ann Card Anaesth; 2010; 13(2):110-5. PubMed ID: 20442540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of high dose aprotinin in liver transplantation: the influence on fibrinolysis and blood loss.
    Grosse H; Lobbes W; Frambach M; von Broen O; Ringe B; Barthels M
    Thromb Res; 1991 Aug; 63(3):287-97. PubMed ID: 1720262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study.
    Dietrich W; Dilthey G; Spannagl M; Jochum M; Braun SL; Richter JA
    Anesthesiology; 1995 Oct; 83(4):679-89; discussion 29A-30A. PubMed ID: 7574046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage.
    Mössinger H; Dietrich W
    Ann Thorac Surg; 1998 Jun; 65(6 Suppl):S45-50; discussion S50-1, S74-6. PubMed ID: 9647138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does aprotinin influence endothelial-associated coagulation in cardiac surgery?
    Boldt J; Schindler E; Knothe C; Hammermann H; Stertmann WA; Hempelmann G
    J Cardiothorac Vasc Anesth; 1994 Oct; 8(5):527-31. PubMed ID: 7528560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pump-prime aprotinin dose in cardiac surgery: appraisal of its effects on the hemostatic system.
    Rossi M; Storti S; Martinelli L; Varano C; Marra R; Zamparelli R; Possati G; Schiavello R
    J Cardiothorac Vasc Anesth; 1997 Dec; 11(7):835-9. PubMed ID: 9412880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose heparin versus full-dose heparin with high-dose aprotinin during cardiopulmonary bypass. A preliminary report.
    von Segesser LK; Garcia E; Turina MI
    Tex Heart Inst J; 1993; 20(1):28-32. PubMed ID: 7685221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha2-plasmin inhibitor complexes and postoperative blood loss.
    Mastroroberto P; Chello M; Zofrea S; Marchese AR
    Eur J Cardiothorac Surg; 1995; 9(3):143-5. PubMed ID: 7540397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mini-dose pump-prime aprotinin inhibited enhanced fibrinolytic activity and reduced blood loss and transfusion requirements after coronary artery bypass surgery.
    Kunt AS; Darcin OT; Aydin S; Demir D; Selli C; Andac MH
    J Thromb Thrombolysis; 2005 Jun; 19(3):197-200. PubMed ID: 16082607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose aprotinin reduces blood loss in patients undergoing total hip replacement surgery.
    Janssens M; Joris J; David JL; Lemaire R; Lamy M
    Anesthesiology; 1994 Jan; 80(1):23-9. PubMed ID: 7507304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients.
    Hardy JF; Desroches J; Belisle S; Perrault J; Carrier M; Robitaille D
    Can J Anaesth; 1993 Jul; 40(7):625-31. PubMed ID: 7691426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypass.
    Spannagl M; Dooijewaard G; Dietrich W; Kluft C
    Thromb Haemost; 1995 May; 73(5):825-8. PubMed ID: 7482410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose and high-dose aprotinin improve hemostasis in coronary operations.
    Speekenbrink RG; Wildevuur CR; Sturk A; Eijsman L
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):523-30. PubMed ID: 8751522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.